Gastroenterology 148:1311-1319.e6
To keep NAD levels consistently elevated, daily dosing is recommended rather than occasional use
N Engl J Med 356:24572471 Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR (2003) Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-y ligand rosiglitazone
Keywords: glucagon-like peptide 1 receptor agonists, semaglutide, salivary glands, xerostomia, cyclic AMP, beta-arrestins Abstract This review addresses the growing concern of oral side effects, particularly dry mouth, associated with semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) widely used for diabetes and obesity
[DOI] [PMC free article] [PubMed] [Google Scholar] 15.Pentikinen PJ, Neuvonen PJ, Penttil A
Lipid droplet protein LID-1 mediates ATGL-1-dependent lipolysis during fasting in Caenorhabditis elegans